Resources

The Prospective Country Evaluation (PCE) is an embedded mixed-methods evaluation platform designed to examine the Global Fund business model, investments and contribution to disease program outcomes and impact in eight countries. The PCE generates timely evidence to support program improvements and accelerate progress towards the objectives of the Global Fund 2017-2022 Strategy.This report presents findings from Uganda from 2019-2020.

The Prospective Country Evaluation (PCE) is an embedded mixed-methods evaluation platform designed to examine the Global Fund business model, investments and contribution to disease program outcomes and impact in eight countries. The PCE generates timely evidence to support program improvements and accelerate progress towards the objectives of the Global Fund 2017-2022 Strategy.This report presents findings from Senegal from 2019-2020.

The Prospective Country Evaluation (PCE) is an embedded mixed-methods evaluation platform designed to examine the Global Fund business model, investments, and contribution to disease program outcomes and impact in eight countries. The PCE generates timely evidence to support program improvements and accelerate progress towards the objectives of the Global Fund 2017-2022 Strategy.This report presents findings synthesized across the eight PCE countries in 2019 with a focus on evaluating progress and analyzing impact of grants funded through the 2017-2019 allocation and implemented during 2018-2019. Findings were structured around three out of the four Global Fund strategic objectives (SOs): grant implementation and contribution to disease impact (SO1); grant contribution to national Resilient and Sustainable Systems for Health outcomes (SO2); and grant contribution to national program key population, human rights, and gender-related outcomes (SO3).

The DMPA-SC Evidence to Practice meetings in 2018 and 2019 have gathered together family planning experts, including ministry officials, partners, and donors from more than 20 countries. Participants met to develop country strategies for increasing voluntary access to subcutaneous DMPA (DMPA-SC) within a wide range of contraceptive methods and to inform related policy decisions with current evidence. These reports summarize the plenaries, presentations, and discussions held to inform country planning. For more information, visit DMPA-SC Evidence to Practice: Increasing access, empowering women; sign up for our newsletter; or email FPoptions@path.org.

Over nearly 20 years, the partnerships forged through efforts to introduce JE vaccination have had an impact that goes beyond JE in the Asian and Western Pacific regions. Not only did these partnerships result in more than 300 million children being protected from JE, they also strengthened health systems across multiple countries.So, what factors led to the project’s success? How can partners use the JE project experience to inform current and future efforts to take on other health challenges? PATH and its partners have compiled five key lessons learned that they hope will inform, challenge, and inspire ongoing efforts against JE, as well as other vaccination projects, to ensure impact and sustainability.